Class information for:
Level 1: GLATIRAMER ACETATE//INTERFERON BETA//INTERFERON BETA 1B

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
346 3545 38.1 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
85 25913 MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GLATIRAMER ACETATE Author keyword 300 66% 8% 278
2 INTERFERON BETA Author keyword 189 36% 12% 420
3 INTERFERON BETA 1B Author keyword 97 68% 2% 85
4 INTERFERON BETA 1A Author keyword 65 57% 2% 78
5 NATALIZUMAB Author keyword 62 33% 4% 158
6 DISEASE MODIFYING THERAPY Author keyword 49 55% 2% 61
7 RELAPSING REMITTING MULTIPLE SCLEROSIS Author keyword 44 40% 2% 87
8 COPOLYMER 1 Author keyword 38 71% 1% 30
9 COPAXONE Author keyword 37 74% 1% 28
10 MULTIPLE SCLEROSIS JOURNAL Journal 33 13% 7% 247

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 GLATIRAMER ACETATE 300 66% 8% 278 Search GLATIRAMER+ACETATE Search GLATIRAMER+ACETATE
2 INTERFERON BETA 189 36% 12% 420 Search INTERFERON+BETA Search INTERFERON+BETA
3 INTERFERON BETA 1B 97 68% 2% 85 Search INTERFERON+BETA+1B Search INTERFERON+BETA+1B
4 INTERFERON BETA 1A 65 57% 2% 78 Search INTERFERON+BETA+1A Search INTERFERON+BETA+1A
5 NATALIZUMAB 62 33% 4% 158 Search NATALIZUMAB Search NATALIZUMAB
6 DISEASE MODIFYING THERAPY 49 55% 2% 61 Search DISEASE+MODIFYING+THERAPY Search DISEASE+MODIFYING+THERAPY
7 RELAPSING REMITTING MULTIPLE SCLEROSIS 44 40% 2% 87 Search RELAPSING+REMITTING+MULTIPLE+SCLEROSIS Search RELAPSING+REMITTING+MULTIPLE+SCLEROSIS
8 COPOLYMER 1 38 71% 1% 30 Search COPOLYMER+1 Search COPOLYMER+1
9 COPAXONE 37 74% 1% 28 Search COPAXONE Search COPAXONE
10 BETA INTERFERON 32 43% 2% 57 Search BETA+INTERFERON Search BETA+INTERFERON

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GLATIRAMER ACETATE 219 48% 9% 335
2 COPOLYMER 1 203 77% 4% 138
3 SECONDARY PROGRESSIVE MS 114 55% 4% 143
4 INTERFERON BETA 1A 114 46% 5% 182
5 SYNTHETIC COPOLYMER 1 102 86% 1% 51
6 INTERFERON BETA 1B 102 42% 5% 185
7 ANTINEOPLASTIC AGENT MITOXANTRONE 93 80% 2% 57
8 INTRAMUSCULAR INTERFERON 92 76% 2% 64
9 RELAPSING MS 92 76% 2% 65
10 SELECTIVE IMMUNOMODULATION 76 78% 1% 50

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MULTIPLE SCLEROSIS JOURNAL 33 13% 7% 247
2 MULTIPLE SCLEROSIS 14 14% 3% 91
3 MULTIPLE SCLEROSIS AND RELATED DISORDERS 8 19% 1% 39
4 THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 1 11% 0% 11

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Multiple sclerosis 2008 1052 151 26%
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use 2015 5 44 57%
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis 2015 4 23 70%
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies 2014 29 106 59%
New management algorithms in multiple sclerosis 2014 20 53 79%
Defining the clinical course of multiple sclerosis The 2013 revisions 2014 45 29 31%
Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis 2013 25 30 87%
Medical progress: Multiple sclerosis. 2000 1730 78 26%
Multiple sclerosis 2002 867 75 33%
Interferon Beta and Glatiramer Acetate Therapy 2013 15 95 91%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEUROBIOL CLIN 19 74% 0.4% 14
2 MULTIPLE SCLEROSIS 18 13% 3.6% 126
3 DANISH MULTIPLE SCLEROSIS 18 36% 1.1% 39
4 MULTIPLE SCLEROSIS CLIN 12 28% 1.0% 35
5 MELLEN MULTIPLE SCLEROSIS TREATMENT 9 22% 1.0% 37
6 SBU THER EUT 9 83% 0.1% 5
7 OUTPATIENT CLIN NEUROL NEUROSURG 8 75% 0.2% 6
8 DANISH MS TREATMENT REGISTER 8 100% 0.1% 5
9 MS CLIN CENT TEXAS 8 100% 0.1% 5
10 CORINNE GOLDSMITH DICKINSON MULTIPLE SCLEROSI 8 36% 0.5% 18

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000208218 CSF CEREBROSPINAL FLUID//SOLUBLE VASCULAR CELL ADHESION MOLECULE 1 SVCAM 1//INTRAVENOUS METHYLPREDNISOLONE
2 0.0000171296 NEUROIMAGING UNIT//NMR UNIT//MR MS
3 0.0000130143 DANISH REGISTER MULTIPLE SCLEROSIS//LUPOID SCLEROSIS//AUTOIMMUNE TAUTOLOGY
4 0.0000127798 KINESIOL COMMUNITY HLTH//MULTIPLE SCLEROSIS JOURNAL//TIMED 25 FOOT WALK
5 0.0000123847 FUMARIC ACID ESTERS//DIMETHYL FUMARATE//DIMETHYLFUMARATE
6 0.0000121015 KRISTIAN GERHARD JEBSEN MS//MULTIPLE SCLEROSIS EPIDEMIOLOGY//NORWEGIAN MULTIPLE SCLEROSIS COMPETENCE
7 0.0000108591 LINOMIDE//ROQUINIMEX//LAQUINIMOD
8 0.0000101169 UCLA MULTIPLE SCLEROSIS PROGRAM//MULTIPLE SCLEROSIS PROGRAM//POSTPARTUM ACTIVATION
9 0.0000096897 IMMUNOFLUORESCENCE CYTOMETRY//ACTIVITY PARAMETER//AUTOLOGOUS MIXED LYMPHOCYTE RESPONSE
10 0.0000093635 FAMILIAL MULTIPLE SCLEROSIS//PROGRAM NEUROPSYCHIAT GENOM//HLA DRB11501